Rethinking Lyme Disease Testing: A New Approach to Early Detection
New research marks a promising step toward rethinking how we identify and manage Lyme disease and related infections in the clinical lab
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
New research marks a promising step toward rethinking how we identify and manage Lyme disease and related infections in the clinical lab
With patient and provider demand for WGS on the rise, what should laboratorians know about ordering and interpreting this testing?
AI can help alleviate the burden on clinical labs—but only with sufficient investment, enthusiasm, and understanding
How three companies are addressing screening challenges with tests that help improve chances of early detection
Computational biology expert Keaun Amani shares his advice and insights on AI and machine learning tools for the clinical lab
How do the underlying datasets affect artificial intelligence tools’ performance in the lab—and beyond?
Many artificial intelligence-based medical devices have not undergone clinical validation—but what does this mean for the lab?
Lab scientists using testing equipment too quickly brings up training concerns in discussions at recent ADLM conference
Expansion of use for two assays gives patients the option to self-collect specimens at home and in the clinic, which may help address gaps in screening
With the global cancer burden growing, is a universal germline genomic testing approach the key to more effectively combating the disease?
Recent advances in pharmacogenomic testing—and their role in ensuring safe, effective treatment selection for precision oncology